Medical Device and Diagnostic Industry (MD+DI)

Next-Gen Sequencing Is Going Global, And 2026 Could Be the Tipping Point

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Le Lézard

Epicrispr Biotechnologies to Present at 44th Annual J.P. Morgan Healthcare Conference

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.
Precision Medicine Online

T-ALL Patients Treated With Base-Edited CAR7 T-Cell Therapy Enter Deep Remission, ASH Data Show

Of the 11 patients treated with BE-CAR7 T cells, seven are in remission, including one patient who has been in remission for three years.
Le Lézard

Daiichi Sankyo Showcases Strength of Industry-Leading ADC Portfolio with Latest Research Updates from Five Landmark Breast Cancer Trials at SABCS

Daiichi Sankyo (TSE: 4568) will present new breast cancer clinical research across its DXd antibody drug conjugate (ADC) portfolio from more than 30 abstracts at the 2025 San Antonio Breast Cancer ...

Bobby Deol pens emotional tribute to 'pyaare papa' Dharmendra on his birth anniversary: 'He-Man ho aap sab ke lekin...'

Bobby Deol also highlighted his father Dharmendra's journey as a star who never left anyone behind and celebrated the pride ...